CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 62 filers reported holding CUE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $58,000 | -56.7% | 26,205 | -51.4% | 0.00% | – |
| Q2 2022 | $134,000 | -65.1% | 53,971 | +104.9% | 0.00% | -100.0% |
| Q3 2021 | $384,000 | +4.1% | 26,340 | -16.8% | 0.00% | 0.0% |
| Q2 2021 | $369,000 | -22.0% | 31,656 | -16.4% | 0.00% | -33.3% |
| Q4 2020 | $473,000 | +23550.0% | 37,846 | +37746.0% | 0.00% | – |
| Q4 2019 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |